Edition:
United Kingdom

Profile: Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

180.00SEK
5:00pm BST
Change (% chg)

-2.00kr (-1.10%)
Prev Close
182.00kr
Open
181.00kr
Day's High
181.00kr
Day's Low
177.20kr
Volume
8,386
Avg. Vol
14,763
52-wk High
216.50kr
52-wk Low
115.00kr

Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.

Company Address

Infant Bacterial Therapeutics AB

Gamla Brogatan 11
STOCKHOLM     111 20
P: +468.41014555

Company Web Links